Lipid Signaling and Lipidomics Laboratory, Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, OH, United States.
Toxicol Mech Methods. 2007;17(9):541-57. doi: 10.1080/15376510701380505.
ABSTRACT Currently, mercury has been identified as a risk factor in cardiovascular diseases among humans. Here, we tested our hypothesis that mercury modulates the activity of the vascular endothelial cell (EC) lipid signaling enzyme phospholipase A(2) (PLA(2)), which is an important player in the EC barrier functions. Monolayers of bovine pulmonary artery ECs (BPAECs) in culture, following labeling of membrane phospholipids with [(3)H]arachidonic acid (AA), were exposed to the inorganic form of mercury, mercury chloride, and the release of free AA (index of PLA(2) activity) and formation of AA metabolites were determined by liquid scintillation counting and enzyme immunoassay, respectively. Mercury chloride significantly activated PLA(2) in BPAECs in a dose-dependent (0 to 50 muM) and time-dependent (0 to 120 min) fashion. Metal chelators significantly attenuated mercury-induced PLA(2) activation, suggesting that cellular mercury-ligand interaction is required for the enzyme activation and that chelators are suitable blockers for mercury-induced PLA(2) activation in ECs. Sulfhydryl (thiol-protective) agents, calcium chelating agents, and cPLA(2)-specific inhibitor also significantly attenuated the mercury-induced PLA(2), suggesting the role of thiol and calcium in the activation of cPLA(2) in BPAECs. Significant formation of AA metabolites, including the release of total prostaglandins, thromboxane B(2), and 8-isoprostane, were observed in BPAECs following their exposure to mercury chloride. Mercury chloride induced cytotoxicity as observed by the altered cell morphology and enhanced trypan blue uptake, which was attenuated by the cPLA(2) inhibitor AACOCF(3). The results of this study revealed that inorganic mercury-induced PLA(2) activation through the thiol and calcium signaling and the formation of bioactive AA metabolites further demonstrated the association of PLA(2) with the cytotoxicity of mercury in ECs. Overall, the results of the current study underscore the importance of PLA(2) signaling in mercury-induced endothelial dysfunctions.
目前,汞已被确定为人类心血管疾病的一个风险因素。在这里,我们检验了我们的假设,即汞调节血管内皮细胞(EC)脂质信号酶磷脂酶 A2(PLA2)的活性,这是 EC 屏障功能的重要参与者。在培养的牛肺动脉内皮细胞(BPAEC)中,用[(3)H]花生四烯酸(AA)标记膜磷脂后,使细胞暴露于无机形式的汞,即氯化汞,通过液体闪烁计数和酶免疫测定分别确定游离 AA 的释放(PLA2 活性指标)和 AA 代谢物的形成。氯化汞以剂量依赖性(0 至 50 μM)和时间依赖性(0 至 120 分钟)方式显著激活 BPAEC 中的 PLA2。金属螯合剂显著减弱了汞诱导的 PLA2 激活,这表明细胞内汞配体相互作用是酶激活所必需的,并且螯合剂是 EC 中汞诱导的 PLA2 激活的合适抑制剂。巯基(硫醇保护)试剂、钙螯合剂和 cPLA2 特异性抑制剂也显著减弱了汞诱导的 PLA2,表明巯基和钙在 BPAEC 中 cPLA2 的激活中起作用。在 BPAEC 暴露于氯化汞后,观察到 AA 代谢物的大量形成,包括总前列腺素、血栓素 B2 和 8-异前列腺素的释放。氯化汞诱导的细胞形态改变和台盼蓝摄取增加导致细胞毒性,cPLA2 抑制剂 AACOCF3 减弱了这种毒性。本研究结果表明,无机汞通过巯基和钙信号诱导 PLA2 激活,并形成生物活性 AA 代谢物,进一步证明 PLA2 与 EC 中汞的细胞毒性有关。总的来说,本研究结果强调了 PLA2 信号在汞诱导的内皮功能障碍中的重要性。